Document is current
Any future updates will be listed below
-
Authors
Caggiano, Christa
Morselli, Marco
Qian, Xiaoyu
Celona, Barbara
Thompson, Michael J.
Wani, Shivangi
Tosevska, Anela
Taraszka, Kodi
Heuer, Galen
Ngo, Shyuan T.
Steyn, Frederick J.
Nestor, Peter J.
Wallace, Leanne
McCombe, Pamela
Heggie, Susan
Thorpe, Kathryn
McElligott, Caitlin
English, Gemyka
Henders, Anjali
Henderson, Robert
Lomen-Hoerth, Catherine
Wray, Naomi R.
McRae, Allan F.
Pellegrini, Matteo
Garton, Fleur C.
Zaitlen, Noah
- License Information
-
More Information
Article History
Received: 14 January 2025
Accepted: 29 August 2025
First Online: 16 October 2025
Declarations
:
: All participants provided written informed consent and the study received approval from the Human Research Ethics Committee at the Royal Brisbane and Women’s Hospital (HREC/17/QRBW/299) and by the UCSF Committee on Human Research (IRB 10–05027). Research conformed to the Declarations of Helsinki.
: Written informed consent was obtained from individuals to publish their clinical details.
: C.C., N.Z., M.M., M.P., and F.C.G. are co-inventors on an international patent application (PCT/US2024/033056, filed June 7, 2024) related to cell-free DNA biomarkers for disease diagnosis and prognosis. N.Z. serves as a scientific advisor and consultant for Dinamo Biotechnologies. The remaining authors declare that they have no competing interests.
